{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:41:39Z","timestamp":1794562899413,"version":"4.9.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":2024,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1477-2574.2011.00312.x","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T06:25:02Z","timestamp":1306823102000},"page":"426-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Bilirubin levels predict malignancy in patients with obstructive jaundice"],"prefix":"10.1016","volume":"13","author":[{"given":"Giuseppe","family":"Garcea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee","family":"Ngu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjsurg.2009.09.011","article-title":"Pancreaticoduodenectomis in patients without periampullary lesions: lesions that masquerade as cancer","volume":"199","author":"Hurtuk","year":"2010","journal-title":"Am J Surg"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/157488709789957547","article-title":"Spectrum of benign lesions mimicking a malignant stricture at the liver hilum","volume":"4","author":"Kassahun","year":"2009","journal-title":"Rev Recent Clin Trials"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0020","first-page":"620","article-title":"CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease","volume":"8","author":"Morris-Stiff","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0025","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1007\/s10620-008-0289-8","article-title":"Elevation of carbohydrate antigen 19-9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration","volume":"53","author":"Ong","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13651820701504207","article-title":"Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study","volume":"9","author":"Sundeep","year":"2007","journal-title":"HPB"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0035","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3748\/wjg.v10.i10.1504","article-title":"Biochemical and radiological predictors of malignant biliary strictures","volume":"10","author":"Al-Mofleh","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1155\/2000\/467567","article-title":"Prospective study of biliary strictures to determine predictors of malignancy","volume":"14","author":"Bain","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/13651820600919860","article-title":"Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy \u2013 implications for timing of resectional surgery and use of biliary drainage","volume":"8","author":"Mansfield","year":"2006","journal-title":"HPB"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-230X-9-30","article-title":"Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy","volume":"9","author":"Leelawat","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjsurg.2008.12.031","article-title":"CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions","volume":"198","author":"Marrelli","year":"2009","journal-title":"Am J Surg"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.dld.2008.11.010","article-title":"Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma","volume":"41","author":"Li","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-139-7-200310070-00006","article-title":"Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease","volume":"7","author":"Romagnuolo","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1148\/radiol.2331031446","article-title":"Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP","volume":"233","author":"Park","year":"2004","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(00)02479-X","article-title":"Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study","volume":"15","author":"Adamek","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0080","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00259-008-0818-x","article-title":"Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangiopancreatography with intraductal ultrasonography and abdominal ultrasound","volume":"35","author":"Schick","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0085","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2007.02.027","article-title":"Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction","volume":"5","author":"Garrow","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1477-2574.2011.00312.x_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/02841850510016018","article-title":"MRI combined with MR cholangiopancreatography versus helical CT in the evaluation of patients with suspected periampullary tumours: a prospective comparative study","volume":"46","author":"Andersson","year":"2005","journal-title":"Acta Radiol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15304469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15304469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:54:39Z","timestamp":1761263679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X15304469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1365182X15304469"],"URL":"https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00312.x","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilirubin levels predict malignancy in patients with obstructive jaundice","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00312.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}